starting dose of retatrutide A Clinician's Guide to Dosing How Much Retatrutide Do You

In the tirzepatide pivotal trials specifically, hair loss was reported in 4.9-5.3% of treatment groups compared to just 0.9% on placebo, yielding a relative risk of 5.67

Medical treatment is provided through partners of Your Big Picture Healthcare, named in the Terms of Service

Take the First Step Towards a Healthier You With Trava Health's unique, patient-centered approach to weight loss medicine in Wyoming, Michigan, you're never alone on your journey to better health

The most commonly reported side effects of retatrutide in clinical trials are gastrointestinal, including nausea, vomiting, diarrhoea, constipation, and decreased appetite, consistent with other GLP-1-based therapies